Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRAMETINIB for Malignant melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,448 adverse event reports in the FDA FAERS database where TRAMETINIB was used for Malignant melanoma.

Most Reported Side Effects for TRAMETINIB

Side Effect Reports % Deaths Hosp.
Pyrexia 1,096 18.8% 113 640
Malignant neoplasm progression 807 13.8% 320 205
Product use in unapproved indication 349 6.0% 33 36
Diarrhoea 325 5.6% 42 183
Nausea 301 5.2% 67 172
Rash 290 5.0% 25 96
Vomiting 289 5.0% 59 187
Fatigue 269 4.6% 39 127
Death 240 4.1% 240 40
Chills 227 3.9% 29 128
Asthenia 193 3.3% 42 92
Drug ineffective 192 3.3% 77 53
Anaemia 184 3.2% 32 124
Off label use 176 3.0% 37 38
Metastatic malignant melanoma 173 3.0% 119 75

Other Indications for TRAMETINIB

Metastatic malignant melanoma (1,604) Product used for unknown indication (505) Non-small cell lung cancer (191) Colorectal cancer (158) Glioma (139) Braf gene mutation (94) Neoplasm (84) Neoplasm malignant (81) Braf v600e mutation positive (80) Ovarian cancer (64)

Other Drugs Used for Malignant melanoma

NIVOLUMAB (10,599) IPILIMUMAB (8,903) DABRAFENIB (5,277) TRAMETINIB DIMETHYL SULFOXIDE (3,841) PEMBROLIZUMAB (3,261) BINIMETINIB (2,613) ENCORAFENIB (2,591) VEMURAFENIB (2,548) COBIMETINIB (1,324) TALIMOGENE LAHERPAREPVEC (562)

Related Pages

TRAMETINIB Full Profile All Malignant melanoma Drugs TRAMETINIB Demographics TRAMETINIB Timeline